欧洲结直肠癌诊断市场预测至 2028 年 - COVID-19 影响和区域分析 - 按方式 [成像测试(结肠镜检查、CT 结肠镜检查、柔性乙状结肠镜检查、胶囊内窥镜检查等)和粪便测试(粪便免疫化学测试 (FIT)、基于愈创木脂的粪便潜血测试和粪便 DNA 测试)]和最终用户(医院、诊断实验室、癌症研究机构等)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 158    |    Report Code: BMIRE00028832    |    Category: Life Sciences

Europe Colorectal Cancer Diagnostics Market

2023年欧洲结直肠癌诊断市场价值为31.4581亿美元,预计到2028年将达到47.0352亿美元。预计2023年至2028年复合年增长率为8.4% .

结直肠癌发病率的增加推动欧洲结直肠癌诊断市场的增长

<结直肠癌是一种发生在结肠或直肠组织的恶性肿瘤。根据欧洲癌症信息系统提供的数据,2020年,在欧盟27个国家中,结直肠癌占所有新诊断癌症的12.7%,占该疾病导致的总死亡率的12.4%。如此高的患病率使其成为第二大癌症。继乳腺癌之后最常发生的癌症,也是继肺癌之后癌症相关死亡的第二大原因。手术是所有阶段结肠癌最常见的治疗方法。在理想情况下,如果癌症在早期被诊断出来,医生可以通过外科手术切除肿瘤。结肠镜检查是结直肠癌诊断的重要筛查测试,已成为常规癌症筛查的一部分。因此,结直肠癌患病率的上升推动了欧洲结直肠癌诊断市场的增长。

欧洲结直肠癌诊断市场概述

< /h3>

欧洲结直肠癌诊断市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。在德国,由于癌症领域的不断发展和癌症患病率的增加,结直肠癌诊断市场预计在未来几年将增长。联邦卫生部的国家癌症计划 (Nationaler Krebsplan des Bundesministeriums für Gesundheit) 为制定癌症检测和质量保证临床癌症登记法 (Gesetz zur Weiterentwicklung der Krebsfrüherkennung und zur Qualitàaml;) 铺平了道路。 tssicherung durch klinische Krebsregister),德国议会于 2013 年批准。该法律规定实施有组织且有质量保证的结肠癌筛查计划。此外,该国的结直肠癌筛查方法为男性和女性在 50-54 岁时每年至少进行五次粪便免疫化学测试 (FIT),然后在 55 岁时进行第一次结肠镜检查,以防所有 FIT 均为阴性。 2019年4月4日,国家层面组织了结直肠筛查工作,由于结直肠癌风险上升,要求50岁以上男性和55岁以上女性接受结肠镜检查。联邦联合委员会 (G-BA) 通过了关于有组织癌症筛查计划的指令 (oKFE-RL)。结直肠癌筛查是此后第一个有组织的项目,从2019年7月开始,健康保险公司定期邀请50岁的参保人进行筛查。因此,结直肠癌患病率的不断上升以及政府对结直肠癌筛查的加强是推动欧洲结直肠癌诊断市场增长的因素之一。

 欧洲结直肠癌到 2028 年癌症诊断市场收入及预测(百万美元)

< span>

欧洲结直肠癌诊断市场细分

欧洲结直肠癌诊断市场分为模式、最终用户和国家。

根据模式,欧洲结直肠癌诊断市场分为影像学测试和粪便测试。 2023年,影像测试领域在欧洲结直肠癌诊断市场中占据更大份额。影像测试市场进一步细分为结肠镜检查、CT结肠造影、柔性乙状结肠镜检查、胶囊内窥镜检查等。基于粪便的测试细分市场细分为粪便免疫化学测试 (fit)、基于愈创木脂的粪便潜血测试 (gFOBT) 和粪便 DNA 测试。

基于对于最终用户,欧洲结直肠癌诊断市场分为医院、诊断实验室、癌症研究机构等。 2023年,医院细分市场在欧洲结直肠癌诊断市场中占据最大份额。

根据国家/地区,欧洲结直肠癌诊断市场分为法国、德国、英国、意大利、西班牙和欧洲其他国家。 2023年,德国占据欧洲结直肠癌诊断市场最大份额。

Medtronic Plc、Illumina Inc、Epigenomics AG、Novigenix SA、F. Hoffmann-La Roche Ltd 、Quest Diagnostics Inc、Siemens Healthineers AG、Bruker Corp 和 Eiken Chemical Co., Ltd 是欧洲结直肠癌诊断市场的领先公司。   



Europe Colorectal Cancer Diagnostics Strategic Insights

Strategic insights for Europe Colorectal Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-colorectal-cancer-diagnostics-market-strategic-framework.webp
Get more information on this report

Europe Colorectal Cancer Diagnostics Report Scope

Report Attribute Details
Market size in 2023 US$ 3,145.81 Million
Market Size by 2028 US$ 4,703.52 Million
Global CAGR (2023 - 2028) 8.4%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 方式
  • 影像学检查
  • 粪便检查
By 最终用户
  • 医院
  • 诊断实验室
  • 癌症研究机构
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Bruker Corp
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Medtronic Plc
  • Novigenix SA
  • Quest Diagnostics Inc
  • Siemens Healthineers AG
  • Get more information on this report

    Europe Colorectal Cancer Diagnostics Regional Insights

    The regional scope of Europe Colorectal Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-colorectal-cancer-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Colorectal Cancer Diagnostics Market

    1. Bruker Corp                                            
    2. Eiken Chemical Co., Ltd.                       
    3. Epigenomics AG                                       
    4. F. Hoffmann-La Roche Ltd                     
    5. Illumina Inc         
    6. Medtronic Plc    
    7. Novigenix SA                                           
    8. Quest Diagnostics Inc                          
    9. Siemens Healthineers AG                     
    Frequently Asked Questions
    How big is the Europe Colorectal Cancer Diagnostics Market?

    The Europe Colorectal Cancer Diagnostics Market is valued at US$ 3,145.81 Million in 2023, it is projected to reach US$ 4,703.52 Million by 2028.

    What is the CAGR for Europe Colorectal Cancer Diagnostics Market by (2023 - 2028)?

    As per our report Europe Colorectal Cancer Diagnostics Market, the market size is valued at US$ 3,145.81 Million in 2023, projecting it to reach US$ 4,703.52 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.

    What segments are covered in this report?

    The Europe Colorectal Cancer Diagnostics Market report typically cover these key segments-

  • 方式 (影像学检查, 粪便检查)
  • 最终用户 (医院, 诊断实验室, 癌症研究机构)
  • What is the historic period, base year, and forecast period taken for Europe Colorectal Cancer Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Colorectal Cancer Diagnostics Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Europe Colorectal Cancer Diagnostics Market?

    The Europe Colorectal Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bruker Corp
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Medtronic Plc
  • Novigenix SA
  • Quest Diagnostics Inc
  • Siemens Healthineers AG
  • Who should buy this report?

    The Europe Colorectal Cancer Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Colorectal Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.